Affordable Access

Evaluation of Once-Weekly Therapy for Tuberculosis Using Isoniazid plus Rifamycins in the Mouse Aerosol Infection Model

Authors
Publisher
American Society for Microbiology
Publication Date
Source
PMC
Keywords
  • Experimental Therapeutics
Disciplines
  • Medicine

Abstract

Once-weekly therapy with combinations of isoniazid plus a rifamycin was tested in the mouse low-dose aerosol infection model against two strains of Mycobacterium tuberculosis. Combinations of isoniazid and rifalizil and isoniazid and rifapentine were both highly effective. These animal model data thus support the evaluation of these regimens under clinical conditions.

There are no comments yet on this publication. Be the first to share your thoughts.